Current trends in biomarker discovery and analysis tools for traumatic brain injury 11 Medical and Health Sciences 1109 Neurosciences

Briana I. Martinez, Sarah Stabenfeldt

Research output: Contribution to journalReview article

Abstract

Traumatic brain injury (TBI) affects 1.7 million people in the United States each year, causing lifelong functional deficits in cognition and behavior. The complex pathophysiology of neural injury is a primary barrier to developing sensitive and specific diagnostic tools, which consequentially has a detrimental effect on treatment regimens. Biomarkers of other diseases (e.g. cancer) have provided critical insight into disease emergence and progression that lend to developing powerful clinical tools for intervention. Therefore, the biomarker discovery field has recently focused on TBI and made substantial advancements to characterize markers with promise of transforming TBI patient diagnostics and care. This review focuses on these key advances in neural injury biomarkers discovery, including novel approaches spanning from omics-based approaches to imaging and machine learning as well as the evolution of established techniques.

Original languageEnglish (US)
Article number16
JournalJournal of Biological Engineering
Volume13
Issue number1
DOIs
StatePublished - Feb 19 2019

Fingerprint

Biomarkers
Neurosciences
Brain
Health
Wounds and Injuries
Cognition
Disease Progression
Learning systems
Patient Care
Imaging techniques
Traumatic Brain Injury
Neoplasms
Therapeutics

Keywords

  • Biomarkers
  • Imaging
  • Machine learning
  • Omics
  • Phage display
  • Traumatic brain injury

ASJC Scopus subject areas

  • Environmental Engineering
  • Biomedical Engineering
  • Molecular Biology
  • Cell Biology

Cite this

@article{599b0601f2554d77b45e6c502870897f,
title = "Current trends in biomarker discovery and analysis tools for traumatic brain injury 11 Medical and Health Sciences 1109 Neurosciences",
abstract = "Traumatic brain injury (TBI) affects 1.7 million people in the United States each year, causing lifelong functional deficits in cognition and behavior. The complex pathophysiology of neural injury is a primary barrier to developing sensitive and specific diagnostic tools, which consequentially has a detrimental effect on treatment regimens. Biomarkers of other diseases (e.g. cancer) have provided critical insight into disease emergence and progression that lend to developing powerful clinical tools for intervention. Therefore, the biomarker discovery field has recently focused on TBI and made substantial advancements to characterize markers with promise of transforming TBI patient diagnostics and care. This review focuses on these key advances in neural injury biomarkers discovery, including novel approaches spanning from omics-based approaches to imaging and machine learning as well as the evolution of established techniques.",
keywords = "Biomarkers, Imaging, Machine learning, Omics, Phage display, Traumatic brain injury",
author = "Martinez, {Briana I.} and Sarah Stabenfeldt",
year = "2019",
month = "2",
day = "19",
doi = "10.1186/s13036-019-0145-8",
language = "English (US)",
volume = "13",
journal = "Journal of Biological Engineering",
issn = "1754-1611",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Current trends in biomarker discovery and analysis tools for traumatic brain injury 11 Medical and Health Sciences 1109 Neurosciences

AU - Martinez, Briana I.

AU - Stabenfeldt, Sarah

PY - 2019/2/19

Y1 - 2019/2/19

N2 - Traumatic brain injury (TBI) affects 1.7 million people in the United States each year, causing lifelong functional deficits in cognition and behavior. The complex pathophysiology of neural injury is a primary barrier to developing sensitive and specific diagnostic tools, which consequentially has a detrimental effect on treatment regimens. Biomarkers of other diseases (e.g. cancer) have provided critical insight into disease emergence and progression that lend to developing powerful clinical tools for intervention. Therefore, the biomarker discovery field has recently focused on TBI and made substantial advancements to characterize markers with promise of transforming TBI patient diagnostics and care. This review focuses on these key advances in neural injury biomarkers discovery, including novel approaches spanning from omics-based approaches to imaging and machine learning as well as the evolution of established techniques.

AB - Traumatic brain injury (TBI) affects 1.7 million people in the United States each year, causing lifelong functional deficits in cognition and behavior. The complex pathophysiology of neural injury is a primary barrier to developing sensitive and specific diagnostic tools, which consequentially has a detrimental effect on treatment regimens. Biomarkers of other diseases (e.g. cancer) have provided critical insight into disease emergence and progression that lend to developing powerful clinical tools for intervention. Therefore, the biomarker discovery field has recently focused on TBI and made substantial advancements to characterize markers with promise of transforming TBI patient diagnostics and care. This review focuses on these key advances in neural injury biomarkers discovery, including novel approaches spanning from omics-based approaches to imaging and machine learning as well as the evolution of established techniques.

KW - Biomarkers

KW - Imaging

KW - Machine learning

KW - Omics

KW - Phage display

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85061989165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061989165&partnerID=8YFLogxK

U2 - 10.1186/s13036-019-0145-8

DO - 10.1186/s13036-019-0145-8

M3 - Review article

VL - 13

JO - Journal of Biological Engineering

JF - Journal of Biological Engineering

SN - 1754-1611

IS - 1

M1 - 16

ER -